Showing results (3251-3260 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|May 16, 2002
Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccinationMartin R Graf, Robert M Prins, William T Hawkins, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2002
Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progressionRobert M Prins, Gail P Scott, Randall E Merchant, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2002
Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinomaSzilvia Mosolits, Michael Steinitz, Ulrika Harmenberg, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2001
The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gammaT J Paradis, E Floyd, J Burkwit, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2001
Infiltration by inflammatory cells required for solar-simulated ultraviolet radiation enhancement of skin tumor growthR Sluyter, G M Halliday
Cancer Immunology, Immunotherapy : CII|July 19, 2001
CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6C Hicks, E Keoshkerian, L Gaudry, et al.
Cancer Immunology, Immunotherapy : CII|October 26, 2001
ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cellsE Gitelson, A Ghose, R Buckstein, et al.
Cancer Immunology, Immunotherapy : CII|October 26, 2001
Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1)H Johnen, H Kulbe, G Pecher
Cancer Immunology, Immunotherapy : CII|October 26, 2001
Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF geneM Kusumoto, S Umeda, A Ikubo, et al.
Cancer Immunology, Immunotherapy : CII|July 25, 2003
Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy useFrançoise Bouet-Toussaint, Jean-Jacques Patard, Alban Gervais, et al.
Pageof 652